Ion Exchange (India) Ltd saw its shares jump by 10.76% in recent trading, hitting a high of Rs 453.50. This surge followed a 'Buy' recommendation from brokerage firm AUM Capital, which highlighted the company's robust long-term potential and set a target price of Rs 468 per share over the next 9-12 months.
Why AUM Capital Recommends 'Buy'
AUM Capital's positive outlook for Ion Exchange shares is rooted in several strategic strengths and growth prospects:
- Diversified Revenue Streams: The company boasts a well-balanced revenue profile, with its engineering division contributing approximately 61% to sales, chemicals 29%, and consumer products 10%. This diversification spans various industries, including solar, pharmaceuticals, petrochemicals, power, steel, and textiles.
- Leadership in Water Treatment: Ion Exchange maintains a strong position within the critical water treatment industry, a sector with increasing global demand.
- Healthy Order Book: As of the first quarter of FY27, the company reported a substantial order book valued at around Rs 2,473 crore, indicating strong future revenue visibility.
- Strategic Acquisition: The June 2023 acquisition of Portugal-based MAPRIL has significantly enhanced Ion Exchange's access to European markets, expanding its international footprint.
- Roha Plant Expansion: The company's Roha plant, currently operating at about 25% capacity, is expected to reach full capacity within approximately four years. This facility has the potential to generate annual sales of Rs 500-550 crore and will enable the local production of advanced ion-exchange resins, catering to both domestic and international demand.
- Global Certifications: Ion Exchange's Water Quality Association (WQA) certification is a key enabler for direct exports to major drinking water treatment markets in North America, the UK, and Europe.
Financial Projections and Operational Insights
AUM Capital projects that Ion Exchange's margins will remain stable, ranging between 18% and 24%. The brokerage also noted that roughly Rs 275 crore of the company's expenditure was invested in its core manufacturing plant, underscoring its commitment to expanding production capabilities.
Ion Exchange, which began as a subsidiary of the UK-based Permutit Company in 1964, became an Indian entity in 1985 after Permutit divested its stake, marking a significant milestone in its corporate journey.